Celldex Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2026 | 9.54 M | $355.12 M | 11.49% | 14.34% |
| BLACKROCK, INC. | 08/07/2026 | 7.00 M | $260.56 M | 30.40% | 10.52% |
| KYNAM CAPITAL MANAGEMENT, LP | 08/14/2026 | 5.32 M | $198.07 M | -8.86% | 8.00% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2026 | 4.69 M | $174.34 M | 124.57% | 7.04% |
| STATE STREET CORP | 08/07/2026 | 3.90 M | $145.13 M | 39.09% | 5.86% |
| FMR LLC | 08/13/2026 | 3.72 M | $138.53 M | -0.70% | 5.59% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 3.46 M | $128.93 M | 17.02% | 5.21% |
| DEEP TRACK CAPITAL, LP | 08/14/2026 | 2.94 M | $109.37 M | 128.91% | 4.42% |
| LOGOS GLOBAL MANAGEMENT LP | 08/14/2026 | 2.10 M | $78.14 M | 366.67% | 3.15% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 2.02 M | $75.26 M | 19.79% | 3.04% |
| EVERSEPT PARTNERS, LP | 08/14/2026 | 1.79 M | $66.45 M | -0.12% | 2.68% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 1.62 M | $60.11 M | 63.43% | 2.43% |
| COMMODORE CAPITAL LP | 08/14/2026 | 1.35 M | $50.23 M | -49.94% | 2.03% |
| BELLEVUE GROUP AG | 08/14/2026 | 1.20 M | $44.65 M | 0.00% | 1.80% |
| BAKER BROS. ADVISORS LP | 08/14/2026 | 1.18 M | $44.00 M | 77.74% | 1.78% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 1.17 M | $43.56 M | -6.60% | 1.76% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 1.07 M | $39.96 M | 1.36% | 1.61% |
| AMERICAN CENTURY COMPANIES INC | 08/12/2026 | 1.04 M | $38.79 M | 21.73% | 1.57% |
| EVENTIDE ASSET MANAGEMENT, LLC | 08/14/2026 | 1.04 M | $38.59 M | 0.00% | 1.56% |
| NOVO HOLDINGS A/S | 08/14/2026 | 1.03 M | $38.14 M | -14.58% | 1.54% |
| ELMIND CAPITAL, LP | 08/14/2026 | 990.00 K | $36.84 M | 14.45% | 1.49% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 08/14/2026 | 989.44 K | $36.82 M | 100.00% | 1.49% |
| FISHER ASSET MANAGEMENT, LLC | 08/04/2026 | 985.68 K | $36.68 M | -2.76% | 1.48% |
| PICTET ASSET MANAGEMENT HOLDING SA | 07/30/2026 | 917.41 K | $34.14 M | -0.68% | 1.38% |
| FORESITE CAPITAL MANAGEMENT VI LLC | 08/14/2026 | 879.71 K | $32.73 M | 178.47% | 1.32% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 863.54 K | $32.13 M | 37.23% | 1.30% |
| ASSENAGON ASSET MANAGEMENT S.A. | 08/21/2026 | 788.70 K | $29.35 M | 438.27% | 1.18% |
| NORTHERN TRUST CORP | 08/13/2026 | 719.65 K | $26.78 M | 24.66% | 1.08% |
| WOODLINE PARTNERS LP | 08/14/2026 | 700.83 K | $26.08 M | 40.13% | 1.05% |
| AFFINITY ASSET ADVISORS, LLC | 08/13/2026 | 700.00 K | $26.05 M | 40.00% | 1.05% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 08/14/2026 | 699.15 K | $26.02 M | 7.52% | 1.05% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 661.24 K | $24.60 M | 382.60% | 0.99% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 655.95 K | $24.41 M | 20.25% | 0.99% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 655.95 K | $24.41 M | 100.00% | 0.99% |
| ALGERT GLOBAL LLC | 08/13/2026 | 647.84 K | $24.11 M | 201.10% | 0.97% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/14/2026 | 619.54 K | $23.05 M | 44.82% | 0.93% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 607.20 K | $22.59 M | -14.32% | 0.91% |
| PANAGORA ASSET MANAGEMENT INC | 08/06/2026 | 572.54 K | $21.30 M | 302.27% | 0.86% |
| NUVEEN, LLC | 08/11/2026 | 568.46 K | $21.15 M | 181.49% | 0.85% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 552.97 K | $20.58 M | 28.72% | 0.83% |
| 5AM VENTURE MANAGEMENT, LLC | 08/14/2026 | 497.27 K | $18.50 M | 0.00% | 0.75% |
| FEDERATED HERMES, INC. | 08/12/2026 | 492.89 K | $18.34 M | 100.00% | 0.74% |
| UBS GROUP AG | 08/13/2026 | 482.00 K | $17.94 M | 62.30% | 0.72% |
| CANDRIAM S.C.A. | 08/13/2026 | 481.13 K | $17.89 M | 72.52% | 0.72% |
| IKARIAN CAPITAL, LLC | 08/14/2026 | 478.50 K | $17.80 M | 3.74% | 0.72% |
| BRAIDWELL LP | 08/14/2026 | 436.65 K | $16.25 M | -67.80% | 0.66% |
| REDMILE GROUP, LLC | 08/14/2026 | 433.92 K | $16.15 M | 65.93% | 0.65% |
| CITIGROUP INC | 08/03/2026 | 404.70 K | $15.06 M | 86.21% | 0.61% |
| PALO ALTO INVESTORS LP | 08/19/2026 | 399.86 K | $14.88 M | 34.90% | 0.60% |
| TSP CAPITAL MANAGEMENT GROUP, LLC | 07/31/2026 | 371.13 K | $13.81 M | -1.07% | 0.56% |
Celldex Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 312 institutional investors and hedge funds held shares of Celldex Therapeutics Inc.. The most heavily invested institutionals were:
WELLINGTON MANAGEMENT GROUP LLP: 9.54 M
BlackRock, Inc.: 7 M
Kynam Capital Management, LP: 5.32 M
PRICE T ROWE ASSOCIATES INC /MD/: 4.69 M
STATE STREET CORP: 3.9 M
FMR LLC: 3.72 M
128.62% of Celldex Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 98.15 M shares in the last 24 months. This purchase volume represents approximately $3.02 B in transactions.